Interventions to Reduce Inappropriate Prescribing of Antipsychotic Medications in People With Dementia Resident in Care Homes: A Systematic Review

Journal of the American Medical Directors Association

Volumn 15, Issue 10, 2014, Pages 706-718

  Thompson Coon, Jo ^a   Abbott, Rebecca ^a   Rogers, Morwenna ^a   Whear, Rebecca ^a   Pearson, Stephen ^b   Lang, Iain ^a   Cartmell, Nick ^c   Stein, Ken ^a  

^a UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^b DEVON PARTNERSHIP NHS TRUST   (United Kingdom)

^c The Surgery Ashburton   (United Kingdom)

Author keywords

Antipsychotic; Care homes; Dementia; Prescribing behavior; Systematic review

Indexed keywords

NEUROLEPTIC AGENT;

DEMENTIA; EDUCATION PROGRAM; HUMAN; INAPPROPRIATE PRESCRIBING; MORBIDITY; MORTALITY; NURSING HOME; QUANTITATIVE STUDY; RESIDENTIAL CARE; REVIEW; SYSTEMATIC REVIEW;

ANTIPSYCHOTIC AGENTS; DEMENTIA; HUMANS; INAPPROPRIATE PRESCRIBING; NURSING HOMES;

EID: 84927694618     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2014.06.012     Document Type: Review

References (54)

1. Schneider L., Dagerman K., Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: Meta-analysis of randomised placebo-controlled trials. JAMA 2005, 294:1934-1943.
2. Ballard C., Creese B., Aarsland D. Atypical antipsychotics for the treatment of behavioural and psychological symptoms of dementia with a particular focus on longer term outcomes and mortality. Expert Opin Drug Saf 2011, 10:35-43.
3. Huybrechts K., Gerhard T., Crystal S., et al. Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: Population-based cohort study. BMJ 2012, 344:1-12.
4. National Institute for Health and Excellence. Dementia: Supporting people with dementia and their carers in health and social care;2006.
5. Alzheimer's Society. Optimising treatment and care for people with behavioural and psychological symptoms of dementia;2011.
6. Azermai M., Petrovic M., Elseviers M., et al. Systematic appraisal of dementia guidelines for the management of behavioural and psychological symptoms. Ageing Res Rev 2012, 11:78-86.
7. Barnes T., Banerjee S., Collins N., et al. Antipsychotics in dementia: Prevalence and quality of antipsychotic drug prescribing in UK mental health services. Br J Psychiatry 2012, 201:221-226.
8. de Vugt M.E., Stevens F., Aalten P., et al. Aprospective study of the effects of behavioral symptoms on the institutionalization of patients with dementia. Int Psychogeriatr 2005, 17:577-589.
9. Vance J. AMDA choosing wisely. J Am Med Dir Assoc 2013;14:639-41.
10. Health and Social Care Information Centre. National Dementia and Antipsychotic Prescribing Audit. Secondary National Dementia and Antipsychotic Prescribing Audit 2012. Available at: . Accessed November 2012. http://www.ic.nhs.uk/dementiaaudit.
11. Nijk R.M., Zuidema S.U., Koopmans R.T.C.M. Prevalence and correlates of psychotropic drug use in Dutch nursing-home patients with dementia. Int Psychogeriatr 2009, 21:485-493.
12. Mann E., Kopke S., Haastert B., et al. Psychotropic medication use among nursing home residents in Austria: A cross-sectional study. BMC Geriatr 2009, 9:18.
13. Richter T., Mann E., Meyer G., et al. Prevalence of psychotropic medication useamong German and Austrian nursing home residents: A comparison of 3 cohorts. JAm Med Dir Assoc 2012, 13:187.e7-187.e13.
14. Fossey J., Ballard C., Juszczak E., et al. Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: Cluster randomised trial. Br Med J 2006, 332:756-758.
15. NHS Centre for Reviews and Dissemination. CRD's guidance for undertaking reviews in health care. York, UK: University of York;2009.
16. Cochrane Effective Practice and Organisation of Care Group. Data Collection Checklist. Secondary Data Collection Checklist. Available at: . Accessed July 29, 2014. http://epoc.cochrane.org/epoc-resources.
17. Effective Public Health Practice Project. Quality Assessment Tool for Quantitative Studies. Secondary Quality Assessment Tool for Quantitative Studies. Available at: . Accessed November 2013. http://www.ephpp.ca/tools.html.
18. Testad I., Ballard C., Bronnick K., et al. The effect of staff training on agitation and use of restraint in nursing home residents with dementia: A single-blind, randomized controlled trial. JClin Psychiatry 2010, 71:80-86.
19. Meador K.G., Taylor J.A., Thapa P.B., et al. Predictors of antipsychotic withdrawal or dose reduction in a randomised controlled rial of provider education. JAm Geriatr Soc 1997, 45:207-210.
20. Avorn J., Soumerai S.B., Everitt D.E., et al. Arandomized trial of a program to reduce the use of psychoactive drugs in nursing homes. NEngl J Med 1992, 327:168-173.
21. Schmidt I., Claesson C.B., Westerholm B., et al. The impact of regular multidisciplinary team interventions on psychotropic prescribing in Swedish nursing homes. JAm Geriatr Soc 1998, 46:77-82.
22. Patterson S.M., Hughes C.M., Crealey G., et al. An evaluation of an adapted U.S. model of pharmaceutical care to improve psychoactive prescribing for nursing home residents in Northern Ireland (Fleetwood Northern Ireland Study). JAm Geriatr Soc 2010, 58:44-53.
23. Hagen B.F., Armstrong-Esther C., Quail P., et al. Neuroleptic and benzodiazepine use in long-term care in urban and rural Alberta: Characteristics and results of an education intervention to ensure appropriate use. Int Psychogeriatr 2005, 17:631-652.
24. Ray W.A., Taylor J.A., Meador K.G., et al. Reducing antipsychotic drug use in nursing homes. A controlled trial of provider education. Arch Intern Med 1993, 153:713-721.
25. Ray W.A., Blazer D.G., Schaffner W., et al. Reducing antipsychotic drug prescribing for nursing home patients: A controlled trial of the effect of an educational visit. Am J Public Health 1987, 77:1448-1450.
26. Ballard C., Powell I., James I., et al. Can psychiatric liaison reduce neuroleptic use and reduce health service utilization for dementia patients residing in care facilities. Int J Geriatr Psychiatry 2002, 17:140-145.
27. Westbury J., Jackson S., Gee P., et al. An effective approach to decrease antipsychotic and benzodiazepine use in nursing homes: The RedUSe project. Int Psychogeriatr 2010, 22:26-36.
28. Westbury J., Tichelaar L., Peterson G., et al. A12-month follow-up study of 'RedUSe": A trial aimed at reducing antipsychotic and benzodiazepine use in nursing homes. Int Psychogeriatr 2011, 23:1260-1269.
29. Monette J., Monette M., Sourial N., et al. Effect of an interdisciplinary educational program on antipsychotic prescribing among residents with dementia in two long-term care centers. JAppl Gerontol 2013, 32:833-854.
30. Vida S., Monette J., Wilchesky M., et al. Along-term care center interdisciplinary education program for antipsychotic use in dementia: Program update five years later. Int Psychogeriatr 2012, 24:599-605.
31. Monette J., Champoux N., Monette M., et al. Effect of an interdisciplinary educational program on antipsychotic prescribing among nursing home residents with dementia. Int J Geriatr Psychiatry 2008, 23:574-579.
32. Earthy A., Collins J., Wong S., et al. Ensuring the appropriate use of neuroleptics. Canadian Nursing Home 2000, 11:5-10.
33. Morrison A. Antipsychotic prescribing in nursing homes: An audit report. Qual Prim Care 2009, 17:359-362.
34. Dahl L.J., Wright R., Xiao A., et al. Quality improvement in long term care: The psychotropic assessment tool (PAT). JAm Med Dir Assoc 2008, 9:676-683.
35. Schultz B.M., Gambert S.R. Minimizing the use of psychoactive medications in the institutionalized elderly. Clinical Gerontologist: The Journal of Aging and Mental Health 1991, 11:80-83.
36. Chakraborty A., Linton C.R. Antipsychotic prescribing in dementia patients in care homes: Proactive in-reach service improved quality of care. Int J Geriatr Psychiatry 2012, 27:1097-1098.
37. Khan F., Curtice M. Non-pharmacological management of behavioural symptoms of dementia. Br J Community Nurs 2011, 16:441-449.
38. Heal C., McCracken A. Review of psychotropic medications and application of problem solving approaches to behavioural management in a dementia specific facility. Geriaction 1998, 16:7-9.
39. Rovner B.W., Edelman B.A., Cox M.P., et al. The impact of antipsychotic drug regulations on psychotropic prescribing practices in nursing homes. Am J Psychiatry 1992, 149:1390-1392.
40. Cornege-Blokland E., Kleijer B.C., Hertogh C.M.P.M., et al. Reasons to prescribe antipsychotics for the behavioral symptoms of dementia: A survey in Dutch nursing homes among physicians, nurses, and family caregivers. JAm Med Dir Assoc 2012, 13:80.e1-80.e6.
41. McCleery J., Fox R. Antipsychotic prescribing in nursing homes. BMJ 2012, 344:e1093.
42. Whitby P. Improve environment to reduce pressure to prescribe antipsychotic drugs in nursing homes. BMJ 2012, 344:e2450.
43. Azermai M., Vander Stichele R., Van Bortel L., et al. Barriers to antipsychotic discontinuation in nursing homes: An exploratory study. Aging Ment Health 2013, 18:346-353.
44. Wood-Mitchell A., James I.A., Waterworth A., et al. Factors influencing the prescribing of medications by old age psychiatrists for behavoural and psychological symptoms of dementia: A qualitative study. Age Ageing 2008, 37:547-552.
45. Long-Foley K., Sudha S., Sloane P.D., et al. Staff perceptions of successful management of severe behavioural problems in dementia special care units. Dementia 2003, 2:105-124.
46. Roe B., Flanagan L., Jack B., et al. Systematic review of descriptive studies that investigated associated factors with the management of incontinence in older people in care homes. Int J Older People Nurs 2013, 8:29-49.
47. Lawrence V., Fossey J., Ballard C., et al. Improving quality of life for people with dementia in care homes: Making psychosocial interventions work. Br J Psychiatry 2012, 201:344-351.
48. Forsetlund L., Eike M.C., Gjerberg E., et al. Effect of interventions to reduce potentially inappropriate use of drugs in nursing homes: A systematic review of randomised controlled trials. BMC Geriatr 2011, 11:16.
49. Marcum Z.A., Handler S.M., Wright R., et al. Interventions to improve suboptimal prescribing in nursing homes: A narrative review. Am J Geriatr Pharmacother 2010, 8:183-200.
50. Alldred D.P., Raynor D.K., Hughes C., et al. Interventions to optimise prescribing for older people in care homes. Cochrane Database Syst Rev 2013, (2):CD009095.
51. Fleming A., Browne J., Byrne S. The effect of interventions to reduce potentially inappropriate antibiotic prescribing in long-term care facilities: A systematic review of randomised controlled trials. Drugs Aging 2013, 30:401-408.
52. Verrue C.L.R., Petrovic M., Mehuys E., et al. Pharmacists' interventions for optimization of medication use in nursing homes: A systematic review. Drugs Aging 2009, 26:37-49.
53. Loganathan M., Singh S., Franklin B.D., et al. Interventions to optimise prescribing in care homes: Systematic review. Age Ageing 2011, 40:150-162.
54. Liberati A., Altman D.G., Tetzlaff J., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: Explanation and elaboration. BMJ 2009, 339:b2700.